Biomarkers for the Prediction of Cardiac Readmission

References

• Orszag PR , EmanuelEJ. Healthcare reform and cost control. N. Engl. J. Med.363, 601–603 (2010).
   PubMed Web of Science ®Google Scholar
• Jencks SF , WilliamsMV, ColemanEA. Rehospitalizations among patients in the medicare fee-for-service program. N. Engl. J. Med.360, 1418–1428 (2009).
   PubMed Web of Science ®Google Scholar
• Agency for Healthcare Research and Quality . Bundled payments for heart failure disease management programs can save money while reducing readmissions: research activities, January 2012, no. 377. Agency for healthcare research and quality. Rockville, MD, USA. http://www.Ahrq.Gov/news/newsletters/research-activities/jan12/0112ra6.Html.
   Google Scholar
• Curtis JP , SchreinerG, WangYet al. All-cause readmission and repeat revascularization after percutaneous coronary intervention in a cohort of medicare patients. J. Am. Coll. Cardiol.54, 903–907 (2009).
   PubMed Web of Science ®Google Scholar
• Litmathe J , KurtM, FeindtP, GamsE, BoekenU. Predictors and outcome of ICU readmission after cardiac surgery. Thorac. Cardiovasc. Surg.57, 391–394 (2009).
   PubMed Web of Science ®Google Scholar
• Ferraris VA , FerrarisSP, HarmonRC, EvansBD. Risk factors for early hospital readmission after cardiac operations. J. Thorac. Cardiovasc. Surg.122, 278–286 (2001).
   PubMed Web of Science ®Google Scholar
• Lahey SJ , CamposCT, JenningsB, PawlowP, StokesT, LevitskyS. Hospital readmission after cardiac surgery. Does “fast track” cardiac surgery result in cost saving or cost shifting?Circulation98, II35–II40 (1998).
   PubMed Web of Science ®Google Scholar
• D'Agostino RS , JacobsonJ, ClarksonM, SvenssonLG, WilliamsonC, ShahianDM. Readmission after cardiac operations: prevalence, patterns, and predisposing factors. J. Thorac. Cardiovasc. Surg.118, 823–832 (1999).
   PubMed Web of Science ®Google Scholar
• Stewart RD , CamposCT, JenningsB, LollisSS, LevitskyS, LaheySJ. Predictors of 30-day hospital readmission after coronary artery bypass. Ann. Thorac. Surg.70, 169–174 (2000).
   PubMed Web of Science ®Google Scholar
• Kogan A , CohenJ, RaananiEet al. Readmission to the intensive care unit after “fast-track” cardiac surgery: risk factors and outcomes. Ann. Thorac. Surg.76, 503–507 (2003).
   PubMed Web of Science ®Google Scholar
• Rockx MA , FoxSA, StittLWet al. Is obesity a predictor of mortality, morbidity and readmission after cardiac surgery? Can. J. Surg. 47, 34–38 (2004).
   PubMed Web of Science ®Google Scholar
• Magnus PC , ChaissonK, KramerRSet al. Causes of 30-day readmission after cardiac surgery in northern New England. Circulation124, A13474 (2011).
   Web of Science ®Google Scholar
• Kogon B , JainA, OsterM, WoodallK, KanterK, KirshbomP. Risk factors associated with readmission after pediatric cardiothoracic surgery. Ann. Thorac. Surg.94, 865–873 (2012).
   PubMed Web of Science ®Google Scholar
• Lassus J , GayatE, MuellerCet al. Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: the Multinational Observational Cohort on Acute Heart Failure (MOCA) study. Int. J. Cardiol.   168 (3), 2186–2194 (2013).
   PubMed Web of Science ®Google Scholar
• de Boer RA , LokDJ, JaarsmaTet al. Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction. Ann. Med.43, 60–68 (2011).
   PubMed Web of Science ®Google Scholar
• Bergler-Klein JK , KlaarU, HegerMet al. Prognostic importance of natriuretic peptides in aortic stenosis. Circ. J. Am. Heart Assoc.108, 2343 (2003).
   Google Scholar
• Berendes E , SchmidtC, Van AkenHet al. A-type and B-type natriuretic peptides in cardiac surgical procedures. Anesth. Analg.98, 11–19 (2004).
   PubMed Web of Science ®Google Scholar
• Niedner MF , FoleyJL, RiffenburghRH, BichellDP, PetersonBM, RodarteA. B-type natriuretic peptide: perioperative patterns in congenital heart disease. Congenit. Heart Dis.5, 243–255 (2010).
   PubMed Web of Science ®Google Scholar
• Bignami E , LandoniG, CrescenziGet al. Role of cardiac biomarkers (troponin I and ck-mb) as predictors of quality of life and long-term outcome after cardiac surgery. Ann. Card Anaesth.12, 22–26 (2009).
   PubMedGoogle Scholar
• Bjessmo S . Increased rehospitalization rate after coronary bypass operation for acute coronary syndrome: a prospective study in 200 patients. Ann. Thorac. Surg.88, 1148–1152 (2009).
   PubMed Web of Science ®Google Scholar
• Wang TJ , WollertKC, LarsonMGet al. Prognostic utility of novel biomarkers of cardiovascular stress: The Framingham Heart Study. Circulation126, 1596–1604 (2012).
   PubMed Web of Science ®Google Scholar
• Bayes-Genis A , de AntonioM, GalanAet al. Combined use of high-sensitivity st2 and ntprobnp to improve the prediction of death in heart failure. Euro. J. Heart Fail.14, 32–38 (2012).
   PubMed Web of Science ®Google Scholar
• Hollan I , BottazziB, CuccovilloI. Increased levels of serum pentraxin 3, a novel cardiovascular biomarker, in patients with inflammatory rheumatic disease. Arthritis Care Res.62, 378–385 (2010).
   PubMed Web of Science ®Google Scholar
• Inoue K , KodamaT, DaidaH. Pentraxin 3: a novel biomarker for inflammatory cardiovascular disease. Int. J. Vasc. Med.2012657025 (2012).
   PubMedGoogle Scholar
• van Kimmenade RR , JanuzziJLJr, EllinorPTet al. Utility of amino-terminal probrain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure. J. Am. Coll. Cardiol.48, 1217–1224 (2006).
   PubMed Web of Science ®Google Scholar
• Brown JR , MacKenzieTA, DaceyLJet al. Using biomarkers to improve the preoperative prediction of death in coronary artery bypass graft patients. J. Extra-Corpor. Technol.42, 293–300 (2010).
   PubMedGoogle Scholar
• Brown JR , ParikhCR, RossCSet al. Impact of perioperative acute kidney injury as a severity index for thirty-day readmission after cardiac surgery. Ann. Thorac. Surg.97 (1), 111–117 (2014).
   PubMed Web of Science ®Google Scholar
• Brown JR , HiseyWM, MarshallEJet al. Acute kidney injury severity and long-term readmission and mortality after cardiac surgery. Ann. Thorac. Surg.102 (5), 1482–1489 (2016).
   PubMed Web of Science ®Google Scholar
• Jacobs JP , AlamSS, OwensSLet al. The association between novel biomarkers and 1-year readmission or mortality after cardiac surgery. Ann. Thorac. Surg.106 (4), 1122–1128 (2018).
   PubMed Web of Science ®Google Scholar
• Brown JR , JacobsJP, AlamSSet al. Utility of biomarkers to improve prediction of readmission or mortality after cardiac surgery. Ann. Thorac. Surg. 106 (5), 1294–1301 (2018).
   PubMed Web of Science ®Google Scholar